Atlas company financials

Edwards Lifesciences Corp

Standardized 18-year financial series for Edwards Lifesciences Corp, built from filing-derived source data and exposed in JSON, CSV, and XLSX so it can feed iterFact artifacts or analyst workflows without hand-entering the numbers.

United StatesCIK 0001099800FY2008 → FY2025

Open JSON Download CSV Download XLSX Quarterly JSON Summary JSON Filing index

Latest fiscal year

FY2025

Revenue

$6.1B

Adjusted EBITDA

—

Net result

$1.1B

Net financial debt

-$2.3B

Latest source: FY2025 filing · published data snapshot generated April 26, 2026

Phase 2 summary

Latest quarter, TTM, and growth are now pre-computed for chat and templates.

Latest quarter revenue

$1.6B

TTM revenue

$5.9B

TTM free cash flow

—

Latest quarter net result

$291.1M

Quarterly coverage: 50 periods · latest quarter FY2025-Q3 · TTM revenue growth -2.4%.

What this gives you

A proof-of-concept company data surface, not a dead PDF shelf.

The same standardized payload behind this page is exposed through downloadable CSV and XLSX files plus a stable JSON route. That makes it usable as a live input to iterFact templates, a spreadsheet handoff, or a future API surface without re-normalizing the source documents again.

Source audit

Official links first, raw iterFact payloads right next to them.

Official sources

SEC EDGAR companyfacts
comparative · edwards-lifesciences-corp-fy2008 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2011-02-28 · Retrieved: 2026-04-26T11:41:19.490061+00:00
SEC EDGAR companyfacts
primary · edwards-lifesciences-corp-fy2011 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2012-02-27 · Retrieved: 2026-04-26T11:41:19.490061+00:00
SEC EDGAR companyfacts
primary · edwards-lifesciences-corp-fy2012 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2013-02-28 · Retrieved: 2026-04-26T11:41:19.490061+00:00
SEC EDGAR companyfacts
primary · edwards-lifesciences-corp-fy2013 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2014-02-28 · Retrieved: 2026-04-26T11:41:19.490061+00:00
SEC EDGAR companyfacts
primary · edwards-lifesciences-corp-fy2014 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2015-02-20 · Retrieved: 2026-04-26T11:41:19.490061+00:00

Ten-year series

Headline company financials by fiscal year

Fiscal year	Revenue	Adj. EBITDA	EBIT	Net result	Op. cash flow	Capex	Net debt	Status
FY2008	1B	—	—	—	153M	-51M	—	comparative annual fact carried from later 10k · missing accounts receivable · missing adjusted ebitda · missing current assets · missing current liabilities · missing ebit · missing inventory · missing net financial debt · missing net result · missing total assets
FY2009	1B	—	—	—	165M	-64M	—	comparative annual fact carried from later 10k · missing adjusted ebitda · missing ebit · missing net financial debt · missing net result
FY2010	1B	—	—	—	251M	-62M	—	missing adjusted ebitda · missing ebit · missing net financial debt · missing net result
FY2011	2B	—	—	—	315M	-83M	—	missing adjusted ebitda · missing ebit · missing net financial debt · missing net result
FY2012	2B	—	—	—	374M	-121M	-122M	missing adjusted ebitda · missing ebit · missing net result
FY2013	2B	—	—	—	473M	-109M	173M	missing adjusted ebitda · missing ebit · missing net result
FY2014	2B	—	—	—	1B	-83M	-56M	missing adjusted ebitda · missing ebit · missing net result
FY2015	2B	—	—	—	550M	-103M	-119M	missing adjusted ebitda · missing ebit · missing net result
FY2016	3B	—	751M	—	704M	-176M

Filing provenance